441 related articles for article (PubMed ID: 34906409)
1. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract][Full Text] [Related]
2. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
[No Abstract] [Full Text] [Related]
3. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
4. Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors.
Mema E; Lane EG; Drotman MB; Eisen CS; Thomas C; Prince MR; Dodelzon K
AJR Am J Roentgenol; 2023 Aug; 221(2):175-183. PubMed ID: 36883774
[No Abstract] [Full Text] [Related]
5. COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.
Lim J; Lee SA; Khil EK; Byeon SJ; Kang HJ; Choi JA
Semin Oncol; 2021; 48(4-6):283-291. PubMed ID: 34836672
[TBL] [Abstract][Full Text] [Related]
6. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
8. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine.
Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
Clin Imaging; 2021 Jul; 75():12-15. PubMed ID: 33486146
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.
Faermann R; Nissan N; Halshtok-Neiman O; Shalmon A; Gotlieb M; Yagil Y; Samoocha D; Friedman E; Sklair-Levy M
Acad Radiol; 2021 Sep; 28(9):1191-1197. PubMed ID: 34257025
[TBL] [Abstract][Full Text] [Related]
10. Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up.
Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
Clin Imaging; 2021 Dec; 80():83-87. PubMed ID: 34298342
[TBL] [Abstract][Full Text] [Related]
11. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.
Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O
Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
[TBL] [Abstract][Full Text] [Related]
13. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer.
Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR
Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962
[TBL] [Abstract][Full Text] [Related]
14. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
15. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731
[TBL] [Abstract][Full Text] [Related]
16. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: a single-centre experience in 285 women.
Marcon M; Catanese C; Scarano AL; Del Grande F; Manganiello M; Palermo M; Rizzo S
Radiol Med; 2023 Oct; 128(10):1217-1224. PubMed ID: 37626156
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical factors and ultrasound features associated with COVID-19 vaccine-related axillary lymphadenopathy: A large group study.
Lim J; Khil EK; Lee SA; Choi JA; Lee KY; Jo SW; Lee J
Clin Imaging; 2024 Jan; 105():110046. PubMed ID: 38039749
[TBL] [Abstract][Full Text] [Related]
19. Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.
Garreffa E; Hamad A; O'Sullivan CC; Hazim AZ; York J; Puri S; Turnbull A; Robertson JF; Goetz MP
Eur J Cancer; 2021 Dec; 159():38-51. PubMed ID: 34731748
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ;
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
